UCal Berkeley Pulls Back Freshman Gene Tests
By GenomeWeb,
GenomeWeb [Quotes CGS's Richard Hayes and Jesse Reynolds]
| 08. 13. 2010
NEW YORK (GenomeWeb News) – The University of California at Berkeley will significantly modify its plan to run genetic tests on 5,000 incoming freshmen this year as part of an educational program after state health regulators judged that the plan involved clinical and medical information that required special handling, the University said in a conference call yesterday.
After meeting with the California Department of Public Health on Wednesday and unsuccessfully making its case for the program, Berkeley agreed that it would not share the test results directly with the incoming students, but it still plans to run the tests anonymously and to conduct other related educational projects.
The tests were intended to give freshman an educational experience about medicine, science, and science policy by testing 5,000 volunteers for three particular genetic variants for metabolism of alcohol, lactose, and folic acid.
But soon after the plan was announced last spring it began to draw fire from outside groups. Critics said that the project would inevitably lead to invasions of student privacy, and that it was unethical because it amounted to the...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...